{"id":"W2914020209","doi":"10.1182/blood-2018-99-116715","title":"Outcomes for Patients with High-Risk Relapsed or Refractory Indolent B-Cell Lymphoma Treated with Copanlisib in the CHRONOS-1 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Follicular lymphoma; Bendamustine; Regimen; Population; Clinical endpoint; Adverse effect; Rituximab; Phases of clinical research; Oncology; Salvage therapy; Neutropenia; Refractory (planetary science); Lymphoma; Gastroenterology; Surgery; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00139515,0.0003546944,0.0006780392,0.0003017014,0.0002929061,0.0009031808,0.0003924257,0.000420463,0.001063384],"category_scores_gemma":[0.000876038,0.0001467437,0.001179025,0.0004397702,0.0002262391,0.0004786026,0.0003960144,0.0008473663,0.0001666212],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007227786,"about_ca_system_score_gemma":0.0007191416,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004872488,"about_ca_topic_score_gemma":0.001443948,"domain_scores_codex":[0.9996471,0.0001203192,0.00003093081,0.00007677331,0.00006820004,0.0000565642],"domain_scores_gemma":[0.9991685,0.00009252984,0.0003596401,0.00005837598,0.00005873522,0.0002622395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1130348,0.002408093,0.7907504,0.00110895,0.003819414,0.001015713,0.0003463661,0.00222139,0.00818359,0.0007401843,0.008069037,0.06830212],"study_design_scores_gemma":[0.0195065,0.044748,0.9150333,0.0002660929,0.002855473,0.002277219,0.0002552249,0.001848293,0.001592305,0.0005085304,0.0110338,0.00007519753],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918022,0.003825377,0.0001531868,0.0001807137,0.00004467725,0.0001758939,0.001553604,0.00001402368,0.002250267],"genre_scores_gemma":[0.9934313,0.0008006867,0.0002932299,0.0003290082,0.0001165373,0.0002611468,0.004292965,0.000005463261,0.0004697053],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00139515,"threshold_uncertainty_score":0.00737834,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01059771592378804,"score_gpt":0.2432308958795799,"score_spread":0.2326331799557919,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}